• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前乳腺MRI上的乳腺实质背景特征与浸润性乳腺癌患者的无病生存期相关吗?

Are background breast parenchymal features on preoperative breast MRI associated with disease-free survival in patients with invasive breast cancer?

作者信息

Kim Jin You, Kim Jin Joo, Lee Ji Won, Lee Nam Kyung, Kim Suk, Nam Kyung Jin, Lee Kyeyoung, Choo Ki Seok

机构信息

Department of Radiology, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, 179, Gudeok-Ro, Seo-Gu, Busan, 49241, Republic of Korea.

Department of Radiology, Biomedical Research Institute, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea.

出版信息

Radiol Med. 2024 Dec;129(12):1790-1801. doi: 10.1007/s11547-024-01914-8. Epub 2024 Nov 4.

DOI:10.1007/s11547-024-01914-8
PMID:39496884
Abstract

OBJECTIVE

To evaluate whether breast parenchymal features of the contralateral breast on preoperative MRI are associated with primary breast cancer characteristics and disease-free survival (DFS) in women with invasive breast cancer.

MATERIALS AND METHODS

Women with newly diagnosed invasive breast cancer who underwent preoperative breast MRI followed by surgery were retrospectively evaluated. Background parenchymal enhancement (BPE) on dynamic contrast-enhanced MRI and background diffusion signal (BDS) on diffusion-weighted MRI of the contralateral breast were qualitatively assessed using a four-category scale: minimal, mild, moderate, or marked. Primary breast cancer characteristics were compared based on the degree of BPE or BDS. Cox proportional hazards models were used to evaluate the association between MRI parenchymal features and DFS after adjusting for clinicopathologic features.

RESULTS

A total of 515 women (mean age, 54 years) were included. Of whom, 46 (8.9%) patients who developed disease recurrence at a median follow-up of 60 months were observed. A high level (moderate/marked) of BPE or BDS was associated with younger age (≤ 45) and premenopausal status (all P < 0.05) compared to a low level (minimal/mild), but it was not associated with primary cancer characteristics such as tumor stage, grade, or subtype. Multivariable Cox proportional hazards analysis demonstrated that larger tumor size (> 2 cm) (hazard ratio [HR], 3.877; P < . 001), triple-negative subtype (HR, 2.440; P = .013), and axillary node metastasis (HR, 1.823; P = .049) were associated with worse DFS. No associations were observed between background parenchymal features and disease outcomes.

CONCLUSIONS

MRI parenchymal features, including BPE and BDS, of the contralateral breast showed no associations with primary breast cancer characteristics or DFS in women with invasive breast cancer.

摘要

目的

评估术前MRI检查时对侧乳腺的实质特征是否与浸润性乳腺癌女性的原发性乳腺癌特征及无病生存期(DFS)相关。

材料与方法

对新诊断为浸润性乳腺癌且术前行乳腺MRI检查并随后接受手术的女性进行回顾性评估。采用四级量表对动态对比增强MRI上的背景实质强化(BPE)和对侧乳腺扩散加权MRI上的背景扩散信号(BDS)进行定性评估:最小、轻度、中度或显著。根据BPE或BDS程度比较原发性乳腺癌特征。在调整临床病理特征后,使用Cox比例风险模型评估MRI实质特征与DFS之间的关联。

结果

共纳入515名女性(平均年龄54岁)。其中,在中位随访60个月时观察到46名(8.9%)患者出现疾病复发。与低水平(最小/轻度)相比,高水平(中度/显著)的BPE或BDS与较年轻年龄(≤45岁)和绝经前状态相关(所有P<0.05),但与肿瘤分期、分级或亚型等原发性癌症特征无关。多变量Cox比例风险分析表明,肿瘤较大(>2cm)(风险比[HR],3.877;P<0.001)、三阴性亚型(HR,2.440;P = 0.013)和腋窝淋巴结转移(HR,1.823;P = 0.049)与较差的DFS相关。未观察到背景实质特征与疾病结局之间的关联。

结论

浸润性乳腺癌女性对侧乳腺的MRI实质特征,包括BPE和BDS,与原发性乳腺癌特征或DFS无关。

相似文献

1
Are background breast parenchymal features on preoperative breast MRI associated with disease-free survival in patients with invasive breast cancer?术前乳腺MRI上的乳腺实质背景特征与浸润性乳腺癌患者的无病生存期相关吗?
Radiol Med. 2024 Dec;129(12):1790-1801. doi: 10.1007/s11547-024-01914-8. Epub 2024 Nov 4.
2
Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.动态对比增强 MRI 在评估 ER 阳性、HER2 阴性、淋巴结阴性浸润性乳腺癌中对侧实质增强与生存结局的相关性中的作用。
J Magn Reson Imaging. 2018 Dec;48(6):1678-1689. doi: 10.1002/jmri.26176. Epub 2018 May 7.
3
Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.背景:术前磁共振成像的实质强化与接受新辅助化疗的乳腺癌患者无复发生存率的关联
Medicine (Baltimore). 2016 Mar;95(9):e3000. doi: 10.1097/MD.0000000000003000.
4
Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.乳腺MRI上的背景实质强化:与新诊断的浸润性乳腺癌患者无复发生存率的关联
Breast Cancer Res Treat. 2017 Jun;163(3):573-586. doi: 10.1007/s10549-017-4217-5. Epub 2017 Mar 27.
5
Kinetic Heterogeneity of Breast Cancer Determined Using Computer-aided Diagnosis of Preoperative MRI Scans: Relationship to Distant Metastasis-Free Survival.利用术前 MRI 扫描的计算机辅助诊断来确定乳腺癌的动力学异质性:与远处无转移生存的关系。
Radiology. 2020 Jun;295(3):517-526. doi: 10.1148/radiol.2020192039. Epub 2020 Mar 31.
6
Association between contralateral background parenchymal enhancement on MRI and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy.MRI 显示对侧背景实质增强与接受新辅助化疗的单侧浸润性乳腺癌患者结局的相关性。
Diagn Interv Imaging. 2022 Oct;103(10):486-494. doi: 10.1016/j.diii.2022.04.004. Epub 2022 May 15.
7
Preoperative MRI Features Associated With Axillary Nodal Burden and Disease-Free Survival in Patients With Early-Stage Breast Cancer.早期乳腺癌患者腋窝淋巴结受累和无病生存与术前 MRI 特征相关。
Korean J Radiol. 2024 Sep;25(9):788-797. doi: 10.3348/kjr.2024.0196.
8
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.基于人群的 MRI 背景实质增强与未来原发性乳腺癌风险的相关性评估。
J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.
9
Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.基于术前磁共振成像放射组学的signature 模型:预测早期乳腺癌患者腋窝淋巴结转移和无病生存的研究
JAMA Netw Open. 2020 Dec 1;3(12):e2028086. doi: 10.1001/jamanetworkopen.2020.28086.
10
Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.动态对比增强 MRI 上的对侧实质增强可作为 ER 阳性/HER2 阴性乳腺癌患者生存的生物标志物重现。
Eur Radiol. 2018 Nov;28(11):4705-4716. doi: 10.1007/s00330-018-5470-7. Epub 2018 May 7.

本文引用的文献

1
Background Breast Parenchymal Signal During Menstrual Cycle on Diffusion-Weighted MRI: A Prospective Study in Healthy Premenopausal Women.背景:月经周期中乳腺实质信号在弥散加权 MRI 中的表现:一项对健康绝经前女性的前瞻性研究。
Korean J Radiol. 2024 Jun;25(6):511-517. doi: 10.3348/kjr.2023.1189.
2
Non-contrast Breast MR Imaging.乳腺非增强磁共振成像
Radiol Clin North Am. 2024 Jul;62(4):661-678. doi: 10.1016/j.rcl.2023.12.009. Epub 2024 Mar 7.
3
Evaluation of Association Between Menstrual Cycle Timing and Quantitative Background Parenchymal Enhancement on Breast MRI in Premenopausal Women.
评价绝经前女性月经周期时间与乳腺 MRI 定量背景实质增强的相关性。
Clin Breast Cancer. 2023 Oct;23(7):e451-e457.e1. doi: 10.1016/j.clbc.2023.07.005. Epub 2023 Jul 25.
4
Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study.MRI 检查中对侧实质增强与乳腺癌患者的长期生存相关:SELECT 研究的结果。
Radiology. 2023 May;307(4):e221922. doi: 10.1148/radiol.221922. Epub 2023 Mar 28.
5
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.新辅助化疗期间的乳腺 MRI:缺乏背景实质增强抑制和治疗反应不佳。
Radiology. 2021 Nov;301(2):295-308. doi: 10.1148/radiol.2021203645. Epub 2021 Aug 24.
6
Fusion of high b-value diffusion-weighted and unenhanced T1-weighted images to diagnose invasive breast cancer: factors associated with false-negative results.高 b 值扩散加权和未增强 T1 加权图像融合诊断浸润性乳腺癌:假阴性结果的相关因素。
Eur Radiol. 2021 Jul;31(7):4860-4871. doi: 10.1007/s00330-020-07644-5. Epub 2021 Jan 14.
7
The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.背景实质强化在乳腺 MRI 与乳腺癌的相关性:一项系统评价和荟萃分析。
Radiology. 2019 Sep;292(3):552-561. doi: 10.1148/radiol.2019182441. Epub 2019 Jun 25.
8
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.基于人群的 MRI 背景实质增强与未来原发性乳腺癌风险的相关性评估。
J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.
9
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.乳腺 MRI 背景实质强化(BPE)的组织病理学特征。
Breast Cancer Res Treat. 2018 Nov;172(2):487-496. doi: 10.1007/s10549-018-4916-6. Epub 2018 Aug 23.
10
Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.动态对比增强 MRI 在评估 ER 阳性、HER2 阴性、淋巴结阴性浸润性乳腺癌中对侧实质增强与生存结局的相关性中的作用。
J Magn Reson Imaging. 2018 Dec;48(6):1678-1689. doi: 10.1002/jmri.26176. Epub 2018 May 7.